Study shows new hair loss treatment as effective as finasteride without the associated side effects
Androgenetic alopecia (AGA), the most common type of hair loss, affects both men and women. Traditional treatments like finasteride inhibit the enzyme 5-alpha reductase (5AR) to reduce dihydrotestosterone (DHT) levels, but they come with potential side effects. A new treatment called Cosmerna takes a different approach by selectively targeting the androgen receptor (AR) in the scalp. Using self-assembled micelle inhibitory RNA (SAMiRNA) nanoparticle-type siRNA, Cosmerna reduces the number of androgen receptors in hair follicles, decreasing DHT binding and degradation. This localized approach minimizes the risk of side effects by leaving hormone levels unaffected. Clinical trials have shown impressive results, with participants experiencing increased hair growth comparable to Finasteride, and most importantly with no reported side effects! Making it a revolutionary over the counter product in the world of hair loss.
The human cost and financial impact of misdiagnosis
This research emphasizes the importance of Second Opinions on healthcare and finance. One finding is that most Americans get a late or misdiagnosed at least once in their lives. It is surprising, however, what consequences this has. The research shows that 30% of misdiagnoses lead to life-threatening situations and that misdiagnoses are responsible for 10% of deaths in patients. This ultimately causes 40 to 80,000 deaths per year in the US alone. The research also shows that there are drastic financial consequences, the impact has been estimated at 750 billion dollars in the US. This corresponds to 30% of the government budget for health care.
Medical tourism competition: The case of Turkey
A study published in the Internatıonal Journal Of Health Management And Tourism (IJHMT) highlights why Turkey is an increasingly popular destination for medical tourism. Some interesting findings are that Turkey ranks as the number 2 in the world with regard to the number of accredited hospitals and that Turkey belongs to the top 10 medical tourist destinations in the world, which can be attributed to the high expertise and technology, accessibility, competitiveness, facilities and low prices. The research also highlights the importance of costs in Turkeys popularity in the medical tourism sector. Prices are often more than 50-75% lower compared to the United States and European countries, making Turkey one of the cheapest in the world.
An initial experience with the use of whole body MRI for cancer screening and regular health checks
This research shows how a full body scan (MRI) can be a useful tool in detecting various types of lesions and can aid physicians in obtaining useful information. The types of lesions in this study included cysts, edemas, and malignant and non-malignant tumours. A few key findings were that there was a significant difference in the number of lesions per person between elderly patients (≥52) and younger patients. There was no significant difference in the number of lesions between men and women, there was however a substantial difference in the type of lesions between men and women.
To cut healthcare costs, more employers are offering second opinion services
A literature study on the usefulness of Second Opinions from an interesting perspective. A study conducted by Mayo Clinic found that no less than 88% of Second Opinions had a different or modified diagnosis. In addition, it has also been found in another study that a second opinion not only contributes to the quality in health care but that there is a clear correlation between Second Opinions and cost savings for employers and the health care system, which became even more pronounced in the long run. Interestingly, a trend in the popularity of Second Opinions for employers and non-life-threatening illnesses was also observed. Contributing factors seem to be patient satisfaction, confidence in treatment, and employee wellbeing and productivity.